Postdoctoral Fellows

Thoracic Oncology Laboratory
UCSF Comprehsive Cancer Center
2340 Sutter St, Room S341
San Francisco, CA 94143-0128
415-502-0555 Phone
415-502-3179 Fax
abeltran@cc.ucsf.edu

Currently, Adam is particularly interested in dissecting the mechanisms of interaction between the Wnt and Hedgehog signalling pathways in context of the stepwise process that leads to esophageal cancer. A recent development in Adam's research is his collaborative effort with UCSF inflammation expert Dr. Lisa Coussens to extrapolate, in a clinically relevant manner, the role of complex inflammatory mechanisms in the development of human esophageal cancer.

Adam has been actively publishing since his arrival at tUCSF and is currently working on the lung cancer chapter of a textbook on cancer stem cells. This book will be the first ever on the field of human cancer and stem cells, and expected to be in press by mid-2008.

415-502-0555 Phone
415-502-3179 Fax
dbravo@cc.ucsf.ucsf.edu

Dawn joined the Thoracic Oncology Laboratory as a postdoctoral fellow from Stanford University where she studied the Wnt pathway in prostate cancer. At Stanford, Dawn won the 2006 NIH Ruth L. Kirschenstein National Research Service Award and her current postdoctoral studies are under the auspices of another 2006 NIH National Research Service Award. Her current project is to study the roles of the Frizzled receptors in the Wnt pathway and to understand their involvement in lung cancer.

415-502-0555 Phone
415-502-3179 Fax 
gclement@cc.ucsf.edu

In 2000, Genevieve received a Masters in Biology from the University of Bern, Switzerland, and subsequently completed her PhD in molecular biology at the University of Lausanne in 2005. It was during her doctoral work, that she first became interested in the Wnt signaling pathway and its implications in human carcinogenesis. Excited by the prospect of translational research, she joined the Thoracic Oncology Laboratory as a postdoctoral researcher in 2005 to study the Wnt signaling pathway in an effort to identify novel therapeutic targets.

Ming-Szu (Eric) Hung is a chest physician in his native Taiwan. He grew up in central Taiwan, in Nantou County, and went on to study medicine at Chang-Gung University in Chianyi (in the northern part of the island). After finishing his MD, he went on to complete a residency in Pulmonary Medicine and Critical Care at Chang-Gung Memorial Hospital. During his residency, he became interested in medical research, so after completing his training he enrolled in a PhD program also at Chang-Gung. As part of his still ongoing graduate work, Eric studied EGFR involvement in lung cancer in the laboratory of Dr. Chang-Ta (Jeff) Yang, incidentally a Jablons lab alumnus.

Here in the Thoracic Oncology Laboratory, Eric is specifically interested in the involvement of Casein Kinase II (CK2) in lung carcinogenesis. CK2 has been implicated in a number of signal transduction pathways, among them Wnt and Akt, and is may serve as a potential target of anti-cancer therapeutic agents.